2nd wave. Can we get more coverage on promising therapeutics about to go into trial like 2 Ph 2 trials oral host directed $BSGM drug MMPD alone &amp; in combo with $GILD REM with @mayoclinic #COVID19 chairman as Principal Inv + ex $CELG CMO &amp; $MRK vaccine head https://t.co/YDbpOWsTr4